Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functionsAndrea R. Shiakolas, Ivelin S. Georgiev, Clinton Holt et al.|Cell Reports Medicine|2021Cited by 80
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blockingAndrea R. Shiakolas, Ivelin S. Georgiev, Kevin J. Kramer et al.|Nature Biotechnology|2022Cited by 56
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J. Kramer, Ivelin S. Georgiev, Nicole V. Johnson et al.|Cell Reports|2021Cited by 28
Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functionsAndrea R. Shiakolas, Ivelin S. Georgiev, Kevin J. Kramer et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 8
Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blockingAndrea R. Shiakolas, Ivelin S. Georgiev, Nicole V. Johnson et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 4